ArticleJournal of diabetes investigation2025

Enhanced renoprotective effects of combined glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus: Real-world evidence.

Jian-Yu Jhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.